Bardet-Biedl Syndrome 21 (BBS21)

External Ids:

OMIM 57 617406 MedGen 42 C4319932 CN241836

MeSH 44 D020788 SNOMED-CT via HPO 69 258211005 41729002 28835009 57190000 312917007 65956007 64969001 162294008 229721007 29164008 62415009 405722004 95695004 1151008 267628004 205131007 414915002 414916001 166603001 166643006 75183008 more

UniProtKB/Swiss-Prot : ⁷⁵ Bardet-Biedl syndrome 21: A form of Bardet-Biedl syndrome, a syndrome characterized by usually severe pigmentary retinopathy, early-onset obesity, polydactyly, hypogenitalism, renal malformation and mental retardation. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease.

MalaCards based summary : Bardet-Biedl Syndrome 21, also known as bbs21, is related to bardet-biedl syndrome 2 and bardet-biedl syndrome 10. An important gene associated with Bardet-Biedl Syndrome 21 is C8orf37 (Chromosome 8 Open Reading Frame 37). Affiliated tissues include heart, kidney and eye, and related phenotypes are obesity and delayed speech and language development

OMIM : ⁵⁷ BBS21 is an autosomal recessive ciliopathy characterized by obesity, postaxial polydactyly, retinal degeneration, and mild cognitive impairment (Heon et al., 2016; Khan et al., 2016). For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900). (617406)

Clinical features from OMIM:

617406

Search Clinical Trials , NIH Clinical Center for Bardet-Biedl Syndrome 21

Search GEO for disease gene expression data for Bardet-Biedl Syndrome 21.